`A0 120 Rev. 08/10
`
`T0:
`
`Mail Stop 8
`Director of the US. Patent and Trademark Office
`P.0. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the US. District Court
`for the District of Delaware
`on the following
`
`I] Trademarks or
`
`[Z Patents.
`
`( E] the patent action involves 35 U.S.C. § 292.):
`
`DOCKET NO.
`
`PLAINTIFF
`
`
`
`
`DATE FILED
`1/26/2015
`
`U.S. DISTRICT COURT
`for the District of Delaware
`
`DEFENDANT
`
`
`
`
`
`SENJU PHARMACEUTICAL CO., LTD., et al.
`
`
`
`PADDOCK LABORATORIES, LLC, et al.
`
`
`
`mm;
`
`
`
`
`
`
`
`
`
`
`
`
`
`4 8 871 813 82
`
`10/28/2014
`
`Senju Pharmaceutical Co., Ltd.
`
`5 8,917 606 B1
`
`1/6/2015
`
`Senju Pharmaceutical Co., Ltd.
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`D Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`1:] Answer
`
`[:1 Cross Bill
`
`[:1 Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`
`
`
`
`
`
`
`
`
`—_
`-—
`__
`——
`
`
`
`
`In the above—entitled case, the following decision has been rendered 0r judgement issued:
`DECISION/JUDGEMENT
`
`
`
` (BY) DEPUTY CLERK
`
`DATE,
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3——Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 1 of 361
`
`LUPIN EX 1047
`
`LUPIN EX 1047
`
`Page 1 of 361
`
`
`
`Case 1:14—cv-06893—JBS—KMW Document 4 Filed 11/03/14 Page 1 of 1 PagelD: 64
`
`
`
`
`Mail Stop 8
`REPORT ON THE
`
`Director of the U.S(.)lf’tz_:::nt and Trademark
`FILING OR DETERMINATION OF AN
`
`
`ACTION REGARDING A PATENT OR
`p0. Box 1450
`
`
`Alexandria, VA 22313—1450
`TRADEMARK
`
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the US. District Court for the District of New Jersey on the following:
`Trademarks or X Patents. (
`the patent action involves 35 U.S.C. § 292.)
`
`
`
`U.S. DISTRICT COURT
`DATE FILED
`DOCKET NO.
`CAMDEN NJ
`1:14—cv—06893-JBS—KMW 11/3/2014
`
`DEFENDANT
`
`
`PLAINTIFF
`INNOPHARMA LICENSING, INC.
`
`SENJU PHARMACEUTICAL CO., LTD.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OR
`TRADEMARK NO.
`1 3 129 431
`2 3 669 290
`3 8 754131
`
`DATE OF PATENT
`OR TRADEMARK
`
`3/6/2012 “
`
`
`3/11/2014 “
`
`
`6/17/2014
`
`
`4 8 871 813
`10/28/2014
`
`__
`
`
`
`
`
`DECISION/1UDGEMENT
`
`
`
`
` CLERK
`
`(BY) DEPUTY CLERK
`s/ Nicholas Zotti
`
`DATE
`11/3/2014
`
`
`
`William T. Walsh
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3——Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`Page 2 of 361
`
`Page 2 of 361
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMIVHSSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`14/261,720
`
`ISSUE DATE
`
`10/28/2014
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`8871813
`
`2014—0545
`
`1021
`
`513
`
`7590
`
`10/08/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above—identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site http://pair.uspto. gov for additional applicants):
`
`Shirou SAWA, Hyogo, JAPAN;
`SENJU PHARMACEUTICAL CO., LTD., Osaka, JAPAN, Assignee (with 37 CFR 1.172 Interest);
`Shuhei FUJITA, Hyogo, JAPAN;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`IR103 (1238119308) Of 361
`
`Page 3 of 361
`
`
`
`PA RT 13 ~ FEMS) TR.:'§.NSM1"1"II=‘1.L
`
`(711131111010 211111511111 11115; 1111111, 11113501111111 11-1111 11111111131111:.l‘eeis}.t1): 1111,1111,
`
`3111111811111 1851.1'1"- 1Eit
`11mlmissi11n1‘rfm‘ Patents
`P1} 3111: 14511
`«91112111111111‘111, V“ginia "125113114511
`
`01:15:13; (5713—273-2S85
`
`
`
`
`
`
`11111111213 ..‘
`‘1
`1131311
`25111111111
`111: 11111131113111! when:
`‘3: 11111 1131111 1111111111111:
`1
`..
`'Z~
`1111‘. 1S
`.1? 11111111111 1‘1131..1(.~'"7‘11101\1“ 1131:: (11:1121111111).13111111;
`11.11 13.131131331111311;
`
`
`1111 1.11;! 113111111 11.1 the cum:3'11 11‘1‘1'
`”3111:1an 1111111‘w‘k
`1111;111:1111.
`.. 11' 1'111‘11‘11‘
`3
`~<
`113131.\p1‘1‘1111‘111 1111111111113: 1111‘. 11111131113};
`3.11 1.13 211111 1313111111
`111 13f 111111111‘1111111‘1;
`
`
`:1 11:111111113;
`31131)}?
`111 13111161111 b}- 111} 1111:011yi11g :1. 1111.13- 11:11:313131111‘111‘1‘. addufi: 111111.111; {13} 11111112111113;
`1111113111111 11131-313 1:13111‘1.11‘11 111:1:111'1'31 111111211311 1311111911».
`31131111811111‘11181'131‘. 11085113110315.
`
`
`1111‘
`‘1 13.411111112115513?1132311113,: 113313311);
`N '
`1.3::- 11s~11 11.31 1113131121111 111;:
`1‘1 111
`
`
`
`1..
`11311111111" H155. 121211113
`1131111111112 1.11.1351‘11 11'.)
`'
`“pun-1:15;
`
`
`
`131111.11 11113wi11g. 1131111
`511113 .13 .333.
`1:111:11 111111111
`:11 11113.3.
`Fapt"
`1.11-1‘ 115 mm lit‘l‘iifil.1111‘ 01' 5113111113. 153' Ll.11‘1\1111\\5011
`
`(.‘if-RI-{E-N'I' 1' .{1 Ex
`
`II."
`
`S‘S {Na-11‘: 1.31:: 81.13111:
`
`1‘ 11:1 my 11:11:31; 01’ 3111133113
`
`
`
`1'31.ROTH. 1.11““) 1“: P1151 CK. LL13.
`
`
`i1 {130 1.3111 131111111. N.W..
`Suite. 400 1321111
`Washingmn, D117. 21.10115- 1503
`
`7.91111“c419 1'31 \iiniling 131‘ Trarmnission
`-
`111-11 «1111 1111:. {.31:111:11
`
`
`
`.
`.13 1111111 1'33 311 8131.1: 111311:
`
`..
`{11113113.
`1'11 being £11:51111111:
`.. 1:11 1111‘. 11111‘ 11111111111111 13911331.
`
`
`
`
`C'ii'JNifiRM-‘CE'EONNC). A11131113.:‘1'1'1C'5N NU. FILINGHik-X'YEI T'iRS'E'NAKED.1N'V‘1'LN'E'“'ZIR 11"E"1"€'}R1\'.E'.YIKIK'TKEE'NO. '
`
`
`
`
`
`" 30
`(1&13’3'31‘2014
`311111.111 SAWA
`2131141054.?
`11131
`1412.61.
`
`
`
`:"1'1C ACID
`1 '
`
`:3
`'1'1'1'1...I‘;O}"' 1N VENE'KJN: AQT'
`
`
`.'.‘.\'1'.'1’.1N E‘YPE
`
`11011911111 1111111111
`{ii‘é'iflSflTf}? 'N'l'iii'}
`1NM!.1114
`
`
`
`
`
`5 1 11-13133000
`
`
`
`1 1'.151mm 111' 1:111'11‘ [105111151112 511111113528 111' 53111113551011 131' "PM:
`.-'\1'1{.1R‘T3‘R" 1’33“
`1?. 1510.1 11111111111; 1:11 1111‘. 131119.111 1113311 1531;11:1191'
`
`
`
`{77.1111 5133')
`
`1
`H} "1111‘. 111111128 1‘11 up 11.1 '1 1'tss'ik1311'csd {“111‘111 111311111111
`...........................”
`
`111' 213‘ms {111. 11111111111111»
`a 1.7111111151 111" can
`-
`1
`Addfi‘is: 1mm 1"“ '
`.
`
`
`1111' ”Ami; 1’11 3. wiggle {11m 33,31:an35-: 11 gm;htixj‘ 1}
`11111111 1111‘. 111131111 1.31" up111
`
`
`111 5 1‘1! (1:3“1112. 11111: 11151318 1S
`"'Cl'1'1"1'1'fl
`
`
`
`
`11111311.
`‘
`.113 "
`..
`'1331'1'11:'11111;1131‘1'1
`
`
`:{139112135'3‘13-‘3fe 5
`55:31 aflaghcd.
`BRIEF
`
`
`1111 ‘1.71111.1ng 1‘11".“0111‘4111111111111-
`
`
`111‘‘111‘1‘ 2111111131
`12.1:1111111131111.
`
`7
`-—...................................................................
`j",
`
`"15-115111531) 11113117113017.15.171.11." ' ‘1‘1'1’3‘ 111‘:- 1-‘111N1‘1-3'1'LF £be "1311‘. 13.111195?" 11.111111 1'.'111'\~'p::}
`
`
`
`
`11' (111 3331311”1‘. 1'1. 1118.1111111‘11 139113111. 1111‘. 11132111119111 11:15. 1.11m; flied far
`11.1.11 agugwém' on 1111‘. 1.1310111
`sip111‘1‘ 15-1111
`11:11:51.1 1111 .
`«11 131“111111 1113 amigm‘t‘ 111-1111
`
`.1111; 21.11.
`.7111
`3. 13111311111 111111131‘mls;:‘1""01 :1 3111311111111: 1111 11111.13: 1111'.
`41111113111.
`
`
`1'111RENUJIT.
`.11: (1".11'1’ and 5.1
`'53; 110R 1'_‘.1'.'3'€_‘-'N'1‘RY)
`
`12.5.1 Co... Ltd.
`
`Suva Sag.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`31'..111311.11;<.1n111113111.1113111.11: Pint“ '.' .‘. ' x; ' ‘ '; 1: - .. " ‘11‘11'11‘ {W111 r1111 b1: 11111111111111 11199111 11}: 31.111111111111111
`1311111111111}; 21 {1111111131111va
`
`411 "1111‘. 13111111111”
`1.1.1: 3} 1111‘. 51111111111131}:
`<41). Payment 1111311915): {P1151911 {11511. 11-11991}- miy p‘rt‘vi111‘1513 paid 1551.1» 121‘. Shawn aims t‘)
`E] 185111: Fee.
`:3 A check is; endosed,
`11..) 11111111111111; 151:9 (N1) 5.1311111 11111113 (11111111111 {11111111111211}
`'58 131131111111 1:131 1.11111111311111.12111111‘1‘"1'6v31‘f‘.8‘13‘1111111‘1'11‘11m
`{3 31111131111? 1.111113: 1 .5: 131111313131;
`B17111: Dis~11.111 is; 139101111 41111113112111 111 1,
`
`
`
`1'3 (image in {7.1115131 811111.11 11mm #155115 5111111‘1551‘'11 15111.»“'1‘ j
`
`
`:3 ,3113131112‘1111wrtifyingmiem 1111111; 11111111811631 1'.1‘111' I'SBXHA and 15111.113111‘
` gm; 1’
`11 [1911' G111 1111 ‘111‘111'11111111'11‘:-n1.
`{311:1} :31 the 11\
`111
`
`\___(_________H'1"'.' 11' 1311'.'11311111111111“ was 115‘“. 111mb 111111131 11111‘11.1 14111113; 31.111113. 11513-1. 1.1351] 11115 box “1111.16 111.1111
`1.311111 111113111111111'13111311111111 91 15111111111211 11:1 11111113 3111111. 51111115
`'
`1...! 13111911811111 changing 11.1 18511113? 11111115112311.11‘1‘11 1'01‘ 11:1
`g'k'kjug‘ 11315-13133 11111111‘1:11.1111111191111111111111111033 151113511':1"‘11111¥1:1111':111 113 11113.11 01‘ 1111:."113
`"‘15'1'gitally signed by
`'
`,- 1.1111.111 awhu'fit
`
`
`U 91311311131111 331111111155; 21111111 11531111» 51111113. SW:
`,...
`
`1111' CPR 1.33
`
` C ee Jr/
` '1"}‘131‘.11 131‘ winked 11.11511:
`
`Regisu‘nritux :.\"11_
`
`3.111111111111111 $1 111.115.11.111: __
`
`Page 4 of 361
`
`13111515 2 1.113
`
`15101.85 P1111131: '10 11} Approved 111111111: iiumgh 1W711.131.03337
`
`(31131131155141033
`
`U..\.' 1311112111 111111 11111131111111; 0117103: 1". 53'. 1315951111111 5"1' 131517.1'}\~1N "
`
`Page 4 of 361
`
`
`
`Electronic Patent Application Fee Transmittal
`
`Filing Date:
`
`25-Apr-2014
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`Utility under 35 USC111(a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`
`USD($)
`
`_—
`
`
`
`Basic Filing:
`
`Miscellaneous Filing:
`
`Patent Appeals and-Interference:
`
`Post-Al|owance-and-Post-lssuance:
`
`Extensigééog-yrfief
`
`Page 5 of 361
`
`
`
`Miscellaneous:
`
`Total in USD (5)
`
`Page 6 of 361
`
`Page 6 of 361
`
`
`
`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`
`
`——
`
`Payment information:
`
`yes—
`Submitted with Payment
`
`CHEEKJR., WARREN M.
`
`figg'gqagmdditional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`—Authorized User
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Page 7 of 361
`
`
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C. F. R. Section 1. 21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Issue Fee Payment (PTO-85B)
`
`AttachA_IF.pdf
`
`421174
`
`701eb6392280ddaff6f0fe49939941191597
`d18
`
`The PDF file has been signed with a digital signature and the legal effect of the document will be based on the contents of the file not the
`digital signature.
`
`Fee Worksheet (SB06)
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Page 8 of 361
`
`Page 8 of 361
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`513
`
`7590
`
`09/05/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`511.641.1113..
`
`Washington, DC 20005-1503
`
`
`
`
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 09/05/2014
`
`14/261,720
`
`04/25/2014
`
`Shirou SAWA
`
`2014—0545
`
`1021
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`12/05/2014
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED.
`SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`Page 9 of 361
`PTOL—85 (Rev. 02/11)
`
`Page 1 0f 3
`
`Page 9 of 361
`
`
`
`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`PO. Box 1450
`Alexandria, Virginia 22313-1450
`or m (571)-273-2885
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`ap ropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change ofaddFESS)
`
`09/05/2014
`7590
`513
`WENDEROTH, LIND & PONACK, L...LP
`1030 15th St
`t N W
`.
`1‘66 ’
`'
`Su1te 400 East
`
`"
`
`Washlngton, DC 20005-1503
`
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`apers. Each additional paper, such as an assignment or formal drawing, must
`gave its own certificate of mailing or transmission.
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273—2885, on the date indicated below.
`
`(Date)
`
`(Depositorsname)
`(Signature)
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
`
` F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/261,720
`
`04/25/2014
`
`Shirou SAWA
`
`2014—0545
`
`1021
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`SOROUSH, LAYLA
`
`$960
`
`1627
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`
`3 Chan e of correspondence address (or Change of Correspondence
`Address orm PTO/SB/ 122) attached.
`
`3 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03—02 or more recent) attached. Use of a Customer
`Vumber is required.
`
`
`
`
`
`$0
`
`$0
`
`$960
`
`12/05/2014
`
`514—619000
`
`2. For printing on the patent front page, list
`(1) The names of up to 3 registered patent attorneys
`or agents OR, alternatively,
`(2) The name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`
`
`
`
`2
`
`3
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`If an assignee is identified below, the document has been filed for
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent.
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) :
`
`'3 Individual
`
`'3 Corporation or other private group entity '3 Government
`
`4a. The following fee(s) are submitted:
`3 Issue Fee
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 A check is enclosed.
`
`
`
`3 Publication Fee (No small entity discount permitted)
`3 Advance Order — # of Copies
`
`5. Change in Entity Status (from status indicated above)
`3 Applicant certifying micro entity status. See 37 CFR 1.29
`
`3 Applicant asserting small entity status. See 37 CFR 1.27
`
`3 Applicant changing to regular undiscounted fee status.
`
`
`
`3 Payment by credit card. Form PTO—2038 is attached.
`3 The Director is hereby authorized to charge the required fee(s), any deficiency, or credits any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`VOTE: Absent a valid certification of Micro Entity Status (see forms PTO/SB/ 15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`VOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`VOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`
`NOTE: This form must be signed in accordance with 37 CFR 1.31 and 1.33. See 37 CFR 1.4 for signature requirements and certifications.
`
`Authorized Signature
`
`Typed or printed name
`
`
`Date
`
`Registration No.
`
`Page 10 of 361
`
`Page 2 of 3
`
`PTOL—85 Part B (10—13) Approved for use through 10/31/2013.
`
`OMB 0651—0033
`
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Page 10 of 361
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
`F {ST NAMED INVENTOR
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/261,720
`
`04/25/2014
`
`Shirou SAWA
`
`2014—0545
`
`1021
`
`513
`
`7590
`
`09/05/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`5.1640013...
`
`Washington, DC 20005-1503
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 09/05/2014
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`(Applications filed on or after May 29, 2000)
`
`The Office has discontinued providing a Patent Term Adjustment (PTA) calculation with the Notice of Allowance.
`
`to eliminate the
`Section 1(h)(2) of the AIA Technical Corrections Act amended 35 U.S.C. 154(b)(3)(B)(i)
`requirement that the Office provide a patent term adjustment determination with the notice of allowance. See
`Revisions to Patent Term Adjustment, 78 Fed. Reg. 19416, 19417 (Apr. 1, 2013). Therefore, the Office is no longer
`providing an initial patent term adjustment determination with the notice of allowance. The Office will continue to
`provide a patent term adjustment determination with the Issue Notification Letter that is mailed to applicant
`approximately three weeks prior to the issue date of the patent, and will include the patent term adjustment on the
`patent. Any request for reconsideration of the patent term adjustment determination (or reinstatement of patent term
`adjustment) should follow the process outlined in 37 CFR 1.705.
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1—(888)—786—0101 or (571)—272—4200.
`
`Page 11 of 361
`PTOL—85 (Rev. 02/11)
`
`Page 3 0f 3
`
`Page 11 of 361
`
`
`
`OMB Clearance and PRA Burden Statement for PTOL-85 Part B
`
`The Paperwork Reduction Act (PRA) of 1995 requires Federal agencies to obtain Office of Management and
`Budget approval before requesting most types of information from the public. When OMB approves an agency
`request to collect information from the public, OMB (i) provides a valid OMB Control Number and expiration
`date for the agency to display on the instrument that will be used to collect the information and (ii) requires the
`agency to inform the public about the OMB Control Number’s legal significance in accordance with 5 CFR
`1320.5(b).
`
`The information collected by PTOL-85 Part B is required by 37 CFR 1.311. The information is required to obtain
`or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary
`depending upon the individual case. Any comments on the amount of time you require to complete this form
`and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, PO. Box 1450, Alexandria, Virginia 22313-1450. DO NOT
`SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, PO. Box
`1450, Alexandria, Virginia 22313-1450. Under the Paperwork Reduction Act of 1995, no persons are required to
`respond to a collection of information unless it displays a valid OMB control number.
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (PL. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant
`to the
`requirements of the Act, please be advised that: (1) the general authority for the collection of this information is
`35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which
`the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission
`related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may result in termination of
`proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records
`may be disclosed to the Department of Justice to determine whether disclosure of these records is required
`by the Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance
`from the Member with respect to the subject matter of the record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having
`need for the information in order to perform a contract. Recipients of information shall be required to
`comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency's
`responsibility to recommend improvements in records management practices and programs, under authority
`of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations
`governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive.
`Such disclosure shall not be used to make determinations about individuals.
`
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication
`of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the
`record was filed in an application which became abandoned or in which the proceedings were terminated
`and which application is referenced by either a published application, an application open to public
`inspection or an issued patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`Page equrcfgnent agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`Page 12 of 361
`
`
`
`
`
`Notice Of Allowability
`
`Application No.
`
`14/261 ,720
`Examiner
`
`Applicant(s)
`
`SAWA ET AL.
`Art Unit
`
`LAYLA SOROUSH
`
`1627
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application.
`If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. IX This communication is responsive to the TD filed on 7/31/14 and approved on 8/1/14.
`
`2. I] An election was made by the applicant in response to a restriction requirement set forth during the interview on
`requirement and election have been incorporated into this action.
`
`; the restriction
`
`3. IX The allowed claim(s) is/are 19-45.
`
`4. [Z Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119( )-(d) or (f).
`a) X All
`b) I:I Some*
`c) I] None
`of the:
`
`1. El Certified copies of the priority documents have been received.
`
`9. D Other
`
`2. X Certified copies of the priority documents have been received in Application No. 10/525,006.
`
`3. El Copies of the certified copies of the priority documents have been received in this national stage application from the
`
`International Bureau (PCT Rule 17.2( )).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE” of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`
`5. I] A SUBSTITUTE OATH OR DECLARATION must be submitted. Note the attached EXAMINER’S AMENDMENT or NOTICE OF
`INFORMAL PATENT APPLICATION (PTO-152) which gives reason(s) why the oath or declaration is deficient.
`
`6. I] CORRECTED DRAWINGS (as “replacement sheets”) must be submitted.
`
`(a) I] including changes required by the Notice of Draftsperson’s Patent Drawing Review ( PTO-948) attached
`
`1) El hereto or 2) I] to Paper No./Mai| Date
`
`(b) I] including changes required by the attached Examiner’s Amendment / Comment or in the Office action of
`Paper No./Mai| Date
`Identifying indicia such as the application number (see 37 CFR 1.84(c)) should be written on the drawings in the front (not the back) of
`each sheet. Replacement sheet(s) should be labeled as such in t